The Christie NHS Foundation Trust

Manchester, Greater Manchester M20 4BX

1 studies enrolling now · 11 studies all time

What they study most

Advanced Cancer, Advanced Renal Cell Carcinoma, Advanced and/or Metastatic Solid Tumours, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, Hodgkin Lymphoma, Mantle-Cell Lymphoma, Metastatic Cancer, Metastatic Renal Cell Carcinoma, Multiple Myeloma, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies — Completed
• Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL) — Completed
• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma — Completed
• Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma — APPROVED_FOR_MARKETING
• Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. — Status unconfirmed
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed
• Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma — Completed
• A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments — Completed
• E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer — Stopped early